Sutro Biopharma Inc (STRO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering STRO.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
STRO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The percent of analysts bearish on the stock of STRO is less than just about 100% of all US stocks.
- The number of analysts covering the stock of STRO is greater than 90.92% of stocks in the small market cap category.
- The percentage of analysts bullish on the stock of STRO is greater than 84.03% of all US stocks.
- The upside potential (average analyst target price relative to current price) of STRO is higher than 29.67% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of STRO is lower than 32.88% of stocks in the small market cap category.
- Sutro Biopharma Inc's average analyst price target is greater than 58.33% of stocks in the small market cap category.
- STRO has a lower change in bullishness amongst analysts than just about 100% of all US stocks.
What is the outlook for STRO? Use POWR Ratings for clearer insight into price direction.